Electrochemical Biosensor Development

The Centre develops electrochemical biosensor platforms designed for specific use cases. These are generally underpinned by gold or carbon electrodes and involve the use of affinity reagents such as aptamers and antibodies.

Electrochemical biosensors have the advantage of being highly sensitive but producible at high volumes for low cost.

Technology:
  • Antimicrobial stewardship
  • Microbial diagnostics
  • Infection prevention
  • Antimicrobial compound/strategy
  • Removal antibiotics/bacteria

Microorganisms:
  • Bacteria
  • Viruses
  • Fungi
  • Yeasts
  • Parasites

Application:
  • Human
  • Veterinary
  • Environmental
  • AgriFood
  • Other

Development stage:
  • Research
  • Development
  • Validation
  • Market entry
  • Marketed product

Organization:
  • Academia
  • Company
  • Institute
  • NGO
  • Government

Partnering:
  • License
  • Joint Venture
  • Co-develop
  • Outsource
  • Sell

Funding organisation:
  • OTHER / NA
  • CARB-X
  • FIND
  • GARDP
  • REPAIR

Infectious disease area:
  • UTI
  • BSI
  • STI
  • RTI
  • GII
  • SSTI
  • CNSI
  • IAI
  • SSI

Geographic origin:
  • Eurasia
  • North America
  • South America
  • Africa
  • Oceania


Open to conversations with a range of potential partner organisations

The Centre for Advanced Measurement Science and Health Translation is located at the University of Strathclyde and hosts a range of research projects and spin out companies. Projects focus on development of new bioanalytical measurement techniques and point of care diagnostic solutions. The Centre is supported by the UK’s National Measurement Laboratory hosted at the Laboratory of the Government Chemist and NHS Lanarkshire

The Centre hosts to spinout companies, Microplate DX – a UTI focused SME and Aureum Diagnostics – a biosafety and general purpose diagnostics company


What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed